ALLOS THERAPEUT (ALTH)
 
Quote Price $1.79
Price change for today in $ -0.01
Price change for today in % -0.56
Open Price $1.79
Previous Close $1.80
Daily Range $1.79 - $1.80
52-Week Range $1.25 - $2.52
Volume 393,884
 
 
Brokerage Analyst Recommendations 
2 Brokerage Firms Covering ALTH
 
 
Strong Buy
0 		Buy
0 		Hold
2		 Sell
0		 Strong Sell
0
Average Broker Recommendation (ABR):3 
 
Description
Allos Therapeutics is a pharmaceutical company focused on developing andcommercializing innovative small molecule drugs, initially for improving cancer treatments. The company's lead product candidate is RSR13. RSR13 is a synthetic small molecule that increases the release of oxygen from hemoglobin, the oxygen-carrying protein contained within red blood cells.
 
11080 CIRCLEPOINT ROAD SUITE 200
WESTMINSTER, CO
80020, USA
Phone: 3034266262
Fax: 303-426-4731
Web: http://www.allos.com
Email: nvestorrelations@allos.com		 Industry:MED-DRUGS
Sector: Medical
Fiscal Year End:December
Last Reported Quarter:03/31/12
Next EPS Date:05/10/12
 
Capital Structure Solvency and Cash Flow
No comments yet. Be the first
make a comment about Capital Structure Solvency and Cash Flow
 
Governance Social Responsibility and Employee Relations
No comments yet. Be the first
make a comment about Governance Social Responsibility and Employee Relations
 
Acquisitions Divestitures and Joint Ventures
No comments yet. Be the first
make a comment about Acquisitions Divestitures and Joint Ventures
 
Recent and Upcoming Events
May 11, 2012 20:42 Allos Therapeutics, Inc. (ALTH) Corporate Event Announcement Notice
May 10, 2012 20:39 Allos Therapeutics, Inc. (ALTH) Corporate Event Announcement Notice
May 10, 2012 07:00 Spectrum Pharmaceuticals and Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos Therapeutics
May 10, 2012 04:51 BUYINS.NET: Market Maker Surveillance Report. CPWM, THC, ALTH, CSCO, MSFT, F, Bullishly Biased Price Friction For Wednesday, May 9th 2012
May 02, 2012 20:40 Allos Therapeutics, Inc. (ALTH) Corporate Event Announcement Notice
May 01, 2012 20:40 Allos Therapeutics, Inc. (ALTH) Corporate Event Announcement Notice
May 01, 2012 18:57 Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Allos Therapeutics, Inc.
Apr 26, 2012 05:01 BUYINS.NET: Market Maker Surveillance Report. GE, ALTH, CSCO, LQMT, CLWR, ERT, Highest Net Sell Volume and Negative Price Friction For Wednesday, April 25th 2012
Apr 25, 2012 00:46 Allos Therapeutics Reports Outcome of Request for Re-examination of CHMP Opinion for Folotyn in Europe
Apr 24, 2012 07:10 Bad News for Allos
Apr 20, 2012 09:54 Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN(R) in Europe
Apr 16, 2012 08:15 Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics
Apr 10, 2012 08:02 Downgrade Alert for Allos Therapeutics (ALTH)
Apr 09, 2012 14:42 Warburg Pincus to sell 24% stake in Allos Therapeutics to Spectrum Pharmaceuticals
Apr 09, 2012 14:31 Spectrum Pharmaceuticals to acquire Allos Therapeutics

 
Major Risks
No comments yet. Be the first
make a comment about Major Risks
 


Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 05:37:51 CDT by WikiMigrationBot.